Clot-busting treatment for stroke after 4.5 hours
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This study tracks people who get a clot-busting medicine for a stroke more than 4.5 hours after symptoms start. It aims to see if this type of treatment is safe and helpful for patients who arrive later, such as after sleeping.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have been diagnosed with a stroke caused by a blocked blood vessel (ischemic stroke).
- Your stroke symptoms started more than 4.5 hours ago, including if you woke up with symptoms.
- You are willing to receive a clot-busting medicine (intravenous thrombolysis).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies the use of a clot-busting medicine called tenecteplase given more than 4.5 hours after a stroke starts. It aims to see if this treatment can help people who wake up with stroke symptoms or whose stroke time is unknown.
This study looks at patients who received a clot-busting drug (intravenous thrombolysis) for their stroke 4.5 to 24 hours after symptoms started. It aims to see how well this works and what happens to them, using data that has already been collected.
This study tests whether a clot-busting medicine given through a vein can help people who have had a stroke in the last 3 months and are now having another stroke. The goal is to see if this treatment is safe and improves recovery.
This trial tests whether a clot-busting medication given through a vein (intravenous thrombolysis) can safely treat acute ischemic stroke within 24 hours in people who have taken a newer oral blood thinner (NOAC) within the last 4 to 48 hours.
This study records information from adults with an acute ischemic stroke (a stroke caused by a blocked artery) who receive clot-busting medicine within 4.5 hours. It may help doctors better understand which patients benefit from treatment and how care decisions are made for certain blocked brain arteries.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
Hear when a new Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.